Entrepreneurial Spirit, Rooted in Tradition. At Mitsubishi Tanabe Pharma Development America (MTDA), we can tout a storied reputation more than 300 years in the making. Our parent company, Mitsubishi Tanabe Pharma Corporation (MTPC), is a research-driven pharmaceutical company with global reach – and one of Japan’s oldest and most respected companies.
Relatively new to the U.S. market, the innovative compounds of the Mitsubishi Tanabe Pharma Group have already enjoyed commercial success under the brand labels of our U.S. partners. In this next phase of development, we plan to bring exciting new compounds to market under our own MT Pharma America label. We’re currently building a new commercial organization and expanding our other functions to support this strategy.
As a senior member of Clinical Development, the Senior Director, Clinical Development will lead the full development team in designing, planning, implementing and executing clinical trials and programs in accordance with company SOPs, and FDA/ICH guidelines and regulations. The incumbent will lead the successful delivery of late stage clinical milestones for the company, drawing on expertise in clinical and regulatory requirements, both local and international, related to the clinical medicine and drug development processes. He/she will lead teams, mentoring and motivating individual team members, to meet overall corporate objectives leading to submission for world-wide marketing applications.
The Senior Director, Clinical Development will be responsible for clinical development strategy, clinical program oversight, and support of clinical interactions with regulatory agencies. He/she will also participate in developing the long-range strategic plans and commercial planning and lead the design, implementation, monitoring, analysis, and reporting of clinical studies supporting his/her program.